Literature DB >> 31381886

Tumor-Promoting Activity of Long Noncoding RNA LINC00466 in Lung Adenocarcinoma via miR-144-Regulated HOXA10 Axis.

Tiangang Ma1, Yanbing Hu2, Yingxue Guo3, Bingdi Yan4.   

Abstract

Previous investigations have implicated long noncoding RNAs in lung adenocarcinoma, which is an aggressive disease with poor prognosis and high mortality. Through the alteration of lung adenocarcinoma-related long noncoding RNA and miRNA based on microarray analysis, our aim was to understand the role of LINC00466 and miR-144 in lung adenocarcinoma progression. The relationship among LINC00466, miR-144, and HOXA10 was also verified. Moreover, to examine whether the LINC00466/miR-144/HOXA10 axis contributed to the cellular processes in lung adenocarcinoma, A549 and XWLC-05 cells were transduced with siRNA LINC00466, siRNA HOXA10, or miR-144 mimic plasmids. Highly expressed LINC00466 and HOXA10 and lowly expressed miR-144 were eventually revealed in lung adenocarcinoma tissues. HOXA10 was down-regulated in response to the overexpression of miR-144, whereas inhibition of LINC00466 decreased its binding to miR-144, thereby up-regulating miR-144, which, in turn, halted the lung adenocarcinoma progression. LINC00466 silencing or miR-144 up-regulation exerted an inhibitory role in the tumorigenicity, invasion, migration, and proliferation, and it also promoted apoptosis of lung adenocarcinoma cells. Furthermore, tumor formation was inhibited by knockdown of LINC00466 or overexpression of miR-144. Taken together, LINC00466 could restrain the miR-144 expression to up-regulate HOXA10 and, therefore, promote lung adenocarcinoma.
Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31381886     DOI: 10.1016/j.ajpath.2019.06.014

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  8 in total

1.  Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma.

Authors:  Xianxian Wu; Zhilin Sui; Hongdian Zhang; Ying Wang; Zhentao Yu
Journal:  Front Oncol       Date:  2020-09-15       Impact factor: 6.244

2.  Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2.

Authors:  Yuan Liang; Dalin Zhang; Linlin Li; Tian Xin; Yuwei Zhao; Rui Ma; Jiang Du
Journal:  Stem Cell Res Ther       Date:  2020-02-26       Impact factor: 6.832

3.  Long Non-Coding RNA LINC00466 Knockdown Inhibits Tongue Squamous Cell Carcinoma Malignancy by Targeting microRNA-493/HMGA2.

Authors:  Chao Hou; Yanli Dong; Bo Du
Journal:  Cancer Manag Res       Date:  2020-12-22       Impact factor: 3.989

4.  LINC00466 Impacts Cell Proliferation, Metastasis and Sensitivity to Temozolomide of Glioma by Sponging miR-137 to Regulate PPP1R14B Expression.

Authors:  Mingfei Zhao; Yijie Shao; Jinfang Xu; Buyi Zhang; Chenguang Li; Jie Gong
Journal:  Onco Targets Ther       Date:  2021-02-19       Impact factor: 4.147

5.  Circ_0010235 Regulates HOXA10 Expression to Promote Malignant Phenotypes and Radioresistance in Non-small Cell Lung Cancer Cells Via Decoying miR-588.

Authors:  Hongyan Zhu; Wenshu Yang; Qingping Cheng; Shuai Yang
Journal:  Balkan Med J       Date:  2022-07-22       Impact factor: 3.570

6.  LncRNA HOXA10-AS functions as an oncogene by binding miR-6509-5p to upregulate Y-box binding protein 1 in gastric cancer.

Authors:  Shanshan Li; Chuanhui Lu; Xinyu Li; Fan Li; Yunfeng Zhao; Meimei Xu; Hongyu Jia; Sibo Yuan
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

7.  MiR-139-5p influences hepatocellular carcinoma cell invasion and proliferation capacities via decreasing SLITRK4 expression.

Authors:  Jisiguleng Wu; Tong Zhang; Yubo Chen; Sigaowa Ha
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

8.  Assessment of HIV-1 integration in tissues and subsets across infection stages.

Authors:  Vincent H Wu; Christopher L Nobles; Leticia Kuri-Cervantes; Kevin McCormick; John K Everett; Son Nguyen; Perla M Del Rio Estrada; Mauricio González-Navarro; Fernanda Torres-Ruiz; Santiago Ávila-Ríos; Gustavo Reyes-Terán; Frederic D Bushman; Michael R Betts
Journal:  JCI Insight       Date:  2020-10-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.